| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.37 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0009 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.02 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.009 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.008 |